Micro-Tech (Nanjing) Co.,Ltd (SHA:688029)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Hemostasis and Closure	921.37M
Hemostasis and Closure Growth	27.07%
Endoscopic Mucosal Resection/Endoscopic Submucosal Dissection Class	350.85M
Endoscopic Mucosal Resection/Endoscopic Submucosal Dissection Class Growth	37.94%
Biopsy Class	246.85M
Biopsy Class Growth	-1.37%
Expansion Class	212.15M
Expansion Class Growth	13.56%
Microwave Ablation Needle	174.04M
Microwave Ablation Needle Growth	41.06%
Endoscopic Retrograde Cholangiopancreatography Class	172.87M
Endoscopic Retrograde Cholangiopancreatography Class Growth	57.60%
Visual Product	97.44M
Visual Product Growth	-48.78%
Proxy	89.77M
Proxy Growth	67.74%
Endoscopic Ultrasonography/Endobronchial Ultrasound Class	43.44M
Endoscopic Ultrasonography/Endobronchial Ultrasound Class Growth	82.38%
Other	102.70M
Other Growth	63.13%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	1.35B
China Growth	18.21%
International	1.04B
International Growth	25.80%